Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
1 clinical trials · Condition
◉ Watch Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy (NCT05410938) | Far Eastern Memorial Hospital | 2022-06-06 |
Track Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.